CTMX
CytomX Therapeutics Inc
2.60$
-3.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
CytomX Therapeutics Inc (CTMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -22 | -26 | -20 | -21 | -20 | -21 | -16 | -16 | -23 | -26 | -18 | -82 | |
| 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.1 | 0.5 | 0.0 | 0.1 | 0.8 | |
| 1.2 | 2.6 | 1.9 | 1.9 | 2.0 | 1.9 | 2.0 | 1.4 | 1.4 | 1.5 | 4.7 | 2.6 | 10 | |
| -22 | -25 | -41 | -15 | -29 | -41 | -48 | -18 | -3.3 | 0.4 | -13 | 0.0 | -16 | |
| 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.3 | |
| -43 | 13 | 45 | 22 | 18 | 15 | 31 | -76 | 0.4 | -14 | -193 | 6.0 | -201 | |
| – | – | – | – | – | – | – | – | – | 3.0 | – | – | – | |
| 30 | 0.2 | 0.2 | 5.1 | 0.0 | 2.2 | 0.0 | 94 | 0.3 | 17 | 234 | 0.5 | 252 | |
| -32 | -8.9 | 19 | 7.1 | -2.6 | -2.5 | 9.6 | 1.4 | -15 | -21 | 16 | -12 | -31 | |
| -18 | -22 | -26 | -20 | -21 | -20 | -21 | -16 | -15 | -23 | -26 | -18 | -82 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.